The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health. They are responsible for regulating all medical devices and medicines in the UK by ensuring they work and are acceptably safe. A large part of their work consists of investigating adverse incidents that are reported and they encourage […]

We are delighted to announce that Pressure Relieving Support Surfaces for Pressure Ulcer Prevention (PRESSURE 2): Clinical and Health Economic Results of a Randomised Controlled Trial have now been published by The Lancet and can be viewed by clicking here Huge thanks to the Trust research teams and patients involved.

BACKGROUND At the Tissue Viability Society (TVS) we’ve served the wound care community for over 39 years. The Tissue Viability Society started as a regional group in 1979, becoming a national society in 1981 and gained its charitable status in the mid 1990s. Today it is an independent registered charity run by a body of […]

The Journal of Tissue Viability (JTV) is the official publication of the Tissue Viability Society and we are proud to announce that the impact factor is  2.831. This is an increase from the previous year of 1.925 and ranks the journal #2 in the JCR Nursing category of 120 journals SCIE database. Also ranking 22/66 […]

This guideline covers assessing and managing urinary incontinence and pelvic organ prolapse in women aged 18 and over. It also covers complications associated with mesh surgery for these conditions. In June 2019, NICE withdrew recommendations 1.8.21 and 1.8.22 on the use of synthetic polypropylene or biological mesh insertion for women with recurrent anterior vaginal wall […]

This final guideline has now been published on the NICE website. You can also find the supporting evidence, as well as all the stakeholder comments that were received during consultation and the responses to these comments. The comments were invaluable in helping to develop and refine the guideline. An equality impact assessment has also been […]

This final guideline has now been published on the NICE website. You can also find the supporting evidence, as well as all the stakeholder comments that were received during consultation and the responses to these comments. The comments were invaluable in helping to develop and refine the guideline. An equality impact assessment has also been […]

NICE supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers in the NHS, because they are associated with increased wound healing compared with non-interactive dressings. UrgoStart dressings are therefore recommended as an option for people with diabetic foot ulcers or venous leg ulcers after any modifiable factors such […]